SFC news published since 2018. See SFC archived content for earlier news articles.
A research project at the University of Strathclyde is set to receive £2.5m as part of a £18.9m funding announcement made today by UK Research and Innovation (UKRI).
The announcement is part of a UKRI pilot initiative to explore how existing UKRPIF-funded research centres and facilities can be enhanced to address net zero carbon emissions targets. The University of Strathclyde is one of nine successful projects located right across the UK which include a wide variety of approaches to reducing carbon emissions.
The University will use the money to transform CMAC, its world class centre for the development and manufacture of medicines, into a sustainable, digitalised ‘lab of the future’.
The investment will reduce greenhouse gas emissions by over 50% across a range of sources and enable the adoption of more sustainable approaches in research laboratories. It will also allow the University to work with partners including AstraZeneca and Pfizer on a further range of net zero measures in areas such as the adoption of smart experimental platforms and reducing carbon emissions from travel. The University hopes its multi-faceted net zero approach will establish a beacon for medicines manufacturing sustainability.
